Deerfield Special Situations Fund, L.P., 10% Owner at Dicerna Pharmaceuticals Inc (DRNA), sold 321,965 shares at $11.54 ($3.7M) on 2014-11-24, disclosed to the SEC on 2014-11-25.
Open-market sale of $3.7M DRNA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 15,499 | $170K | 4.7% |
| 2 | $11.00 | 39,377 | $433K | 11.8% |
| 3 | $11.00 | 45,124 | $496K | 13.6% |
| 4 | $11.54 | 1,300 | $15K | 0.4% |
| 5 | $11.54 | 3,303 | $38K | 1.0% |
| 6 | $11.54 | 3,785 |
| $44K |
| 1.2% |
| 7 | $11.55 | 14,199 | $164K | 4.5% |
| 8 | $11.55 | 36,074 | $417K | 11.4% |
| 9 | $11.55 | 41,339 | $477K | 13.1% |
| 10 | $11.50 | 18,903 | $217K | 5.9% |
| 11 | $11.50 | 48,027 | $552K | 15.1% |
| 12 | $11.50 | 55,035 | $633K | 17.3% |
| Total | $11.36 avg | 321,965 | $3.7M | 100% |
| Filing → |
| VNDA | BUY | 2015-12-18 | $3.7M | — | Filing → |
| VNDA | BUY | 2015-12-11 | $6.4M | — | Filing → |
| ALIM | BUY | 2015-12-08 | $494K | — | Filing → |